EyePoint (EYPT) Research & Development (2010 - 2026)
EyePoint (EYPT) recorded Research & Development of $83.61 million in Q2 2026, up 50.7% from $55.5 million a year earlier and up 15.9% from the prior quarter.
Powered by 
Analysis
EyePoint (EYPT) Research & Development (2010 - 2026) Analysis & Trends
On a TTM basis, EyePoint's Research & Development came in at $262.73 million as of Jun 30, 2026, up 40.5% year-over-year; for FY2025, it was $221.04 million, up 66.3% from FY2024.
- Annual Research & Development has increased for six straight years, with a five-year compound annual growth rate of 66.2% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $132.93 million in FY2024 (+105.6%), $64.66 million in FY2023 (+30.3%), $49.64 million in FY2022 (+74.2%) and $28.5 million in FY2021 (+63.6%).
- The Q2 2026 figure is the highest quarterly Research & Development in data going back to Q1 2019.
- On a year-over-year basis, Research & Development has increased for 24 consecutive quarters, with growth averaging 70.5% over the last eight quarters.
- Across the past five years, year-over-year growth in Research & Development ran from 15.5% in Q4 2023 to 141.6% in Q4 2024.
- Per Business Quant, the preceding three quarters came in at $72.15 million (Q1 2026), $59.21 million (Q4 2025) and $47.75 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | EyePoint | 281.29 Mn | -631.84 Mn | 507,000.00 | 83.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 83.61 Mn |
| Mar 31, 2026 | 72.15 Mn |
| Dec 31, 2025 | 59.21 Mn |
| Sep 30, 2025 | 47.75 Mn |
| Jun 30, 2025 | 55.50 Mn |
| Mar 31, 2025 | 58.57 Mn |
| Dec 31, 2024 | 43.37 Mn |
| Sep 30, 2024 | 29.54 Mn |
| Jun 30, 2024 | 29.82 Mn |
| Mar 31, 2024 | 30.14 Mn |
| Dec 31, 2023 | 17.95 Mn |
| Sep 30, 2023 | 17.36 Mn |
| Jun 30, 2023 | 15.73 Mn |
| Mar 31, 2023 | 13.62 Mn |
| Dec 31, 2022 | 15.54 Mn |
| Sep 30, 2022 | 11.16 Mn |
| Jun 30, 2022 | 12.99 Mn |
| Mar 31, 2022 | 9.95 Mn |
| Dec 31, 2021 | 8.92 Mn |
| Sep 30, 2021 | 8.50 Mn |
API Access
EyePoint Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=EYPT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "EYPT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=EYPT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();